DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Peñate Y, Hernández-Machín B, Pérez-Méndez LI et al.
Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma.
Br J Dermatol 2012;
167: 174-179
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.